Sana Biotechnology SANA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$47.21M+4.4% | -$58.83M-19.9% | -$42.15M+29.7% | -$93.8M-86.5% | -$49.39M+54.0% | ||
| $2.39M-34.5% | —— | $3.2M-22.0% | $2.9M-25.6% | $3.65M-2.6% | ||
| $5.66M-19.4% | $6.34M-1.5% | $5.48M-49.2% | $6.63M-41.7% | $7.02M-22.8% | ||
| $454K+111% | -$189K-108% | -$357K+29.6% | —— | -$4.22M-297% | ||
| -$7.09M+20.2% | —— | —— | -$2.99M— | -$8.89M+9.4% | ||
| -$1.63M-19.0% | —— | -$1.12M— | —— | -$1.37M-157% | ||
| $2.62M-20.1% | $3.1M-3.9% | $2.08M-30.5% | $2.52M— | $3.27M-33.0% | ||
| $2.47M+10.5% | $2.39M+9.7% | $2.32M+9.6% | $2.23M+8.8% | $2.23M-33.1% | ||
| $10.75M+476% | $8.58M+397% | —— | $6.3M+287% | $1.86M-65.4% | ||
| -$37.38M+23.2% | -$32.64M+30.8% | -$29.43M+43.2% | -$33.1M+43.5% | -$48.66M+25.9% | ||
| $288K+112% | $873K+100% | $41K-99.0% | —— | $136K-99.1% | ||
| $248K-2.0% | $661K— | $136K— | $382K— | $253K— | ||
| $49.44M+198% | -$16.5M-135% | -$48.03M— | $7.68M— | $16.6M+121% | ||
| $59K-94.8% | $16.68M— | $109.47M— | $0-100% | $1.13M-77.1% | ||
| -$128K-113% | $17.65M+2,645% | $109.54M+5,161% | $561K-94.7% | $982K-99.5% | ||
| $11.93M+138% | -$31.49M— | —— | -$24.86M— | -$31.07M-171% | ||
| $10.75M+476% | $8.58M+397% | —— | $6.3M+287% | $1.86M-65.4% | ||
| -$2.31M-2,586% | $5.51M+152% | $5.12M— | $3.96M— | $93K-99.7% | ||
| $2.39M-34.5% | —— | $3.2M-22.0% | $2.9M-25.6% | $3.65M-2.6% | ||
| -$7.09M+20.2% | —— | —— | -$2.99M— | -$8.89M+9.4% | ||
| $1.5M+268% | $1.46M+183% | $1.46M+984% | $972K+160% | -$891K+84.6% | ||
| -$1.63M-19.0% | —— | -$1.12M— | —— | -$1.37M-157% | ||
| $2.47M+10.5% | $2.39M+9.7% | $2.32M+9.6% | $2.23M+8.8% | $2.23M-33.1% | ||
| $2.62M-20.1% | $3.1M-3.9% | $2.08M-30.5% | $2.52M— | $3.27M-33.0% | ||
| $248K-2.0% | $661K— | $136K— | $382K— | $253K— | ||
| $96K+60.0% | —— | —— | —— | $60K— | ||
| $91K+7.1% | —— | —— | —— | $85K— | ||
| $59K-94.8% | $1.06M+51.5% | $157K-91.9% | $333K-90.3% | $1.13M-77.1% | ||
| $0-100% | —— | —— | —— | $891K-85.4% | ||
| —— | -$681K+62.5% | -$681K+62.5% | -$681K+62.5% | -$681K+62.5% | ||
| -$37.67M+22.8% | -$33.51M+29.6% | -$29.47M+47.3% | -$32.99M+53.9% | -$48.79M+40.1% | ||
| -$37.67M+22.8% | -$33.51M+29.6% | -$29.47M+47.3% | -$32.99M+53.9% | -$48.79M+40.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sana Biotechnology generate?
- Sana Biotechnology (SANA) generated -$132.6M in operating cash flow over the trailing twelve months.
- What is Sana Biotechnology's free cash flow?
- After $1.3M of capital expenditures, Sana Biotechnology's free cash flow was -$133.6M over the trailing twelve months, up 40.3% year over year.
- Where does Sana Biotechnology's cash flow data come from?
- Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.